To test this hypothesis, we used pharmacologic and genetic manipulations of TLR4 and its downstream signaling pathways to define the cell-specific and signaling pathway effects of TLR4 in vitro and in a murine model of CFH-induced acute lung injury. This evidence concerns the gene TLR4 and injury.